Study of Adjuvant ONO-4538 With Resected Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
Pharmacokinetics and Metabolism of [14C]BMS-986165 in Healthy Male Participants
- Status
- COMPLETED
- Phase
- PHASE1
2015-10: Expanded Natural Killer Cells and Elotuzumab for High-Risk Myeloma Post- Autologous Stem Cell Transplant (ASCT)
- Status
- WITHDRAWN
- Phase
- PHASE2
Bleeding Events and Oral Anticoagulant Treatment in Non-Valvular Atrial Fibrillation
- Status
- WITHDRAWN
- Phase
- N/A
An Exploratory Study of the Effects of Nivolumab Combined With Ipilimumab in Patients With Treatment-Naive Stage IV or Recurrent Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate Safety of Single Doses of BMS-986177 in Patients With End Stage Renal Disease (ESRD) Treated With Hemodialysis
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Test Combination Treatments in People With Advanced Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Pilot Study of Nivolumab in Pediatric Patients With Hypermutant Cancers
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Antibody DS-8273a Administered in Combination With Nivolumab in Subjects With Advanced Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Observational Study of Nivolumab Monotherapy or in Combination With Ipilimumab in Participants With Advanced Melanoma and in Participants With Adjuvant Nivolumab Therapy
- Status
- COMPLETED
- Phase
- N/A
Kentucky LEADS Collaborative: Lung Cancer Survivorship Care Program
- Status
- COMPLETED
- Phase
- NA
Nivolumab With or Without Stereotactic Radiosurgery in Treating Patients With Recurrent, Advanced, or Metastatic Chordoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of Nivolumab Plus Ipilimumab, Ipilimumab Alone, or Cabazitaxel in Men With Metastatic Castration-Resistant Prostate Cancer (CheckMate 650)
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate the Pharmacokinetics of BMS-986141 in Participants With Hepatic Impairment Compared to Healthy Participants
- Status
- WITHDRAWN
- Phase
- PHASE1
A Dose Escalation and Cohort Expansion Study of NKTR-214 in Combination With Nivolumab and Other Anti-Cancer Therapies in Patients With Select Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of DS-8273a With Nivolumab in Unresectable Stage III or Stage IV Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate the Safety of Nivolumab and Ipilimumab in Subjects With Previously Untreated Advanced or Metastatic Renal Cell Cancer
- Status
- COMPLETED
- Phase
- PHASE4
Single-dose Pharmacokinetics of BMS-986177 in Participants With Hepatic Impairment Compared to Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of the Safety and Pharmacokinetics of Apixaban Versus Vitamin K Antagonist (VKA) or Low Molecular Weight Heparin (LMWH) in Pediatric Subjects With Congenital or Acquired Heart Disease Requiring Anticoagulation
- Status
- COMPLETED
- Phase
- PHASE2